260 related articles for article (PubMed ID: 6547011)
1. [Computer calculations on the effect of urine components on saturation relations of calcium oxalate in the urine].
Matouschek E; Huber RD
Urologe A; 1984 Mar; 23(2):70-6. PubMed ID: 6547011
[TBL] [Abstract][Full Text] [Related]
2. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
Hassani MA; Hennequin C; Lacour B; Daudon M
Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
[TBL] [Abstract][Full Text] [Related]
3. Changes in urinary composition of calcium oxalate stone formers.
Rahman B; Rahman MA
Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
[TBL] [Abstract][Full Text] [Related]
4. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
5. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate.
Pak CY; Maalouf NM; Rodgers K; Poindexter JR
J Urol; 2009 Dec; 182(6):2951-6. PubMed ID: 19846163
[TBL] [Abstract][Full Text] [Related]
6. [Calcium oxalate activity products and discriminant analysis of urinary parameters as basis for a calcium oxalate screening program (author's transl)].
Brundig P; Berg W; Naumann J; Hoppe H; Cumme GA; Achilles W; Schneider HJ
Urologe A; 1980 Jan; 19(1):54-6. PubMed ID: 7355530
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
[TBL] [Abstract][Full Text] [Related]
8. Effects of citrate on the different phases of calcium oxalate crystallization.
Tiselius HG; Berg C; Fornander AM; Nilsson MA
Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
[TBL] [Abstract][Full Text] [Related]
9. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
10. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
Burdette DC; Thomas WC; Finlayson B
J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
[TBL] [Abstract][Full Text] [Related]
11. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
12. [Effect of urine alkalization on excretion of renal citrate and degree of urine saturation with calcium oxalate in patients with calcium-oxalate urolithiasis and in healthy subjects].
Boruczkowska A
Pol Arch Med Wewn; 1994 Feb; 91(2):77-83. PubMed ID: 8008619
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of calcium oxalate values as indicators of risk for calcium oxalate calcinosis and the degree of urine saturation in patients with calcium urolithiasis and in healthy patients].
Głuszek J; Boruczkowska A; Kosicka T; Raszeja-Wanic B
Pol Tyg Lek; 1989 Feb; 44(9):220-2. PubMed ID: 2813183
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
Boruczkowska A
Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
[TBL] [Abstract][Full Text] [Related]
15. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
Rodgers A
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
[TBL] [Abstract][Full Text] [Related]
16. Different estimates of the risk of calcium oxalate crystallization in urine.
Tiselius HG
Eur Urol; 1983; 9(4):231-4. PubMed ID: 6873126
[TBL] [Abstract][Full Text] [Related]
17. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.
Siener R; Hesse A
Eur Urol; 2002 Sep; 42(3):289-96. PubMed ID: 12234515
[TBL] [Abstract][Full Text] [Related]
18. [The effect of mineral water containing calcium on supersaturation of urine with calcium oxalate].
Gutenbrunner C; Gilsdorf K; Hildebrandt G
Urologe A; 1989 Jan; 28(1):15-9. PubMed ID: 2922895
[TBL] [Abstract][Full Text] [Related]
19. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
20. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
